Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06801795 · ClinicalTrials.gov registry record · NA
Aviclear for Hidradenitis Suppurativa (HS)
A NA study of Hidradenitis Suppurativa, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06801795: Recruiting NA study of Hidradenitis Suppurativa, sponsored by University of Miami.
NCT06801795 is a NA study of Hidradenitis Suppurativa that is actively recruiting participants, run by University of Miami. The registered enrollment target is 8 participants, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06801795, a NA study of Hidradenitis Suppurativa, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) for the treatment of HS.
Primary Outcome
Percentage of participants achieving Hidradenitis Suppurativa Clinical Response 50 (HiSCR50, where HiSCR50 is defined as at least a 50% reduction from baseline in abscess and inflammatory nodule (AN) count, with no increase from baseline in abscess or draining fistula count.
Conditions Studied
Interventions
- DEVICE AviClear
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2025-02-12 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What NCT06801795 shows while recruiting
NCT06801795 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 1 intervention - of which AviClear is the first listed.
NCT06801795 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06801795 about?
NCT06801795 is a clinical study titled "Aviclear for Hidradenitis Suppurativa (HS)". The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) for the treatment of HS.
What is the current status of trial NCT06801795?
This trial is currently recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2025-02-12. Estimated completion is 2026-03-01.
What conditions does trial NCT06801795 study?
This clinical trial studies the following conditions: Hidradenitis Suppurativa.
What interventions are being tested in trial NCT06801795?
The interventions under investigation include: AviClear (DEVICE).
Who is sponsoring clinical trial NCT06801795?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06801795 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hidradenitis Suppurativa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06801795's enrollment target sits among peer trials
8 52nd of 52 higher than 1 of 52 other Hidradenitis Suppurativa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hidradenitis Suppurativa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Physical Activity in Hidradenitis Suppurativa (HS)
RECRUITING · NA
-
Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
RECRUITING · NA
-
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin
RECRUITING · NA
-
Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa
COMPLETED · NA
-
Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa
COMPLETED · NA
-
Hidradenitis Suppurativa (HS) Tunneling Wounds
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI